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Abstract
The superficial dorsal horn (laminae I and II) of the spinal cord contains numerous excitatory and inhibitory interneurons, 
and recent studies have shown that each of these groups can be divided into several neurochemically distinct populations. 
Although it has long been known that some neurons in this region have intersegmental (propriospinal) axonal projections, 
there have been conflicting reports concerning the number of propriospinal cells and the extent of their axons. In addition, 
little is known about the neurochemical phenotype of propriospinal neurons or about the termination pattern of their axons. 
In the present study we show, using retrograde tracing, that around a third of lamina I–II neurons in the lumbar enlargement 
project at least five segments cranially. Substance P-expressing excitatory neurons are over-represented among these cells, 
accounting for one-third of the propriospinal neurons. In contrast, inhibitory interneurons and excitatory PKCγ neurons are 
both under-represented among the retrogradely labelled cells. By combining viral vector-mediated Cre-dependent anterograde 
tracing with immunocytochemistry, we provide evidence that the lateral spinal nucleus (LSN), rather than the superficial 
dorsal horn, is the main target for axons belonging to propriospinal substance P-expressing neurons. These findings help to 
resolve the discrepancies between earlier studies and have implications for the role of the LSN in pain mechanisms.
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Introduction
The spinal dorsal horn receives a highly ordered input from 
primary afferents coding for various somatosensory modali-
ties. This information is processed by local interneurons and 
modulated by descending axons before being transmitted 
to the brain, and to reflex circuits in deeper laminae. The 
superficial dorsal horn (laminae I–II) has attracted particular 
interest, because it is the main target for nociceptive afferents 
(Peirs and Seal 2016). This region contains densely packed 
neurons, the vast majority of which have axons that remain 
in the spinal cord, and are, therefore, defined as interneurons 
(Todd 2017). Interneurons in laminae I–II can be divided 
into two broad classes: inhibitory (GABAergic/glycinergic) 
cells account for ~ 25% of the total population, while excita-
tory (glutamatergic) cells make up the remaining ~ 75% (Pol-
gár et al. 2013). Recent studies have demonstrated that each 
of these classes can be subdivided into neurochemically dis-
tinct populations, and have begun to attribute specific func-
tional roles to these populations (Todd 2017).
Although all interneurons in laminae I–II appear to have 
axons that arborise locally (Grudt and Perl 2002; Yasaka 
et al. 2010), it has been reported that these cells can also 
have propriospinal axons that extend for several segments. 
However, while there have been several studies of proprio-
spinal neurons in the deep dorsal horn (laminae III–VI) and 
ventral horn (Flynn et al. 2011; Brockett et al. 2013), much 
less is known about the organisation of intersegmental con-
nections in the superficial laminae. Bice and Beal (1997b) 
reported that many lamina I and II neurons in the L1 seg-
ment of the rat were retrogradely labelled following applica-
tion of Fluorogold to the hemisected spinal cord at T5. When 
neurons with supraspinal projections were accounted for 
(Bice and Beal 1997a), their findings suggested that around 
10% of neurons in laminae I–II have long propriospinal 
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axons, but do not project to the brain. However, Petko and 
Antal (2000, 2012), who made restricted injections of tracers 
into different regions of the rat L4 dorsal horn, concluded 
that neurons in laminae I–II had relatively short axonal pro-
jections to the dorsal horn of other segments, with very few 
extending more than a segment rostrally or caudally. One 
possible explanation for the discrepancy between these find-
ings is that neurons in laminae I–II have long propriospinal 
axons that terminate outside the dorsal horn, for example, 
in the lateral spinal nucleus (LSN), which is known to be 
innervated by dorsal horn neurons (Cliffer et al. 1988).
The first aim of the present study was to determine 
whether the mouse has a similar propriospinal projection 
pattern involving superficial dorsal horn neurons to that 
described for the rat (Bice and Beal 1997b), and if so, 
whether this involves excitatory and/or inhibitory neurons. 
Substance P-containing axons originating from dorsal horn 
neurons are thought to innervate the LSN (Cliffer et al. 1988; 
Giesler and Elde 1985), and we have recently shown that 
substance P is expressed by a distinct subset of the excita-
tory interneurons in laminae I–II (Gutierrez-Mecinas et al. 
2017). We, therefore, looked for evidence that these cells 
were included among those with long propriospinal projec-
tions, and we compared these to a different population of 
excitatory interneurons, those that express protein kinase 
Cγ (PKCγ). To identify substance P-expressing neurons, 
we used mice with Cre recombinase knocked into the Tac1 
locus, which codes for preprotachykinin A (PPTA, the pre-
cursor for substance P). We performed intraspinal injection 
of adenoassociated viruses (AAVs) with Cre-dependent 
expression cassettes, because we have shown that this strat-
egy reveals dorsal horn neurons that express PPTA in adult 
animals (Gutierrez-Mecinas et al. 2017). This approach also 
allowed us to follow axons belonging to these cells, and, 
therefore, to identify the targets of the propriospinal sub-
stance P neurons.
Materials and methods
Animals
All experiments were approved by the Ethical Review Pro-
cess Applications Panel of the University of Glasgow, and 
were performed in accordance with the European Commu-
nity directive 86/609/EC and the UK Animals (Scientific 
Procedures) Act 1986.
To identify propriospinal neurons with axons that 
ascended for at least five segments, and to determine whether 
these included substance P-expressing cells, we performed 
intraspinal injections of the retrograde tracer cholera toxin B 
subunit (CTb) and of an AAV that codes for a Cre-dependent 
form of eGFP (AAV.flex.eGFP) in  Tac1Cre knock-in mice 
(Harris et al. 2014). The virus (AAV serotype 1) encodes 
an inverted sequence for eGFP between pairs of heterotypic 
LoxP sites with anti-parallel orientation (Atasoy et al. 2008) 
and is under transcriptional control by the CAG promoter. In 
infected cells that express Cre at the time of injection, there 
will be permanent reversal of the coding sequence, resulting 
in expression of eGFP (Gutierrez-Mecinas et al. 2017). Four 
 Tac1Cre mice of either sex aged 6–9 weeks (16–27 g) were 
anaesthetised with isoflurane and placed in a stereotaxic 
frame. The vertebral column was exposed, and each mouse 
received two intraspinal injections through a glass micropi-
pette (inner diameter of tip 40 µm) into the dorsal horn on 
the right side, 300–400 µm lateral to the midline and at a 
depth of 300 µm below the pial surface. The first injection 
consisted of 150 nl of 1% CTb, and was targeted on the T13/
L1 spinal segments by inserting the pipette between the T11 
and T12 vertebrae. The second injection consisted of 300 nl 
of AAV.flex.eGFP (17.2 or 8.6 × 108 gene copies; Penn Vec-
tor Core, Philadelphia, PA, USA) and was targeted on the L5 
spinal segment by injecting between T13 and L1 vertebrae. 
Both injections were administered at a rate of 30 nl/min. The 
wound was closed, and animals were allowed to recover with 
appropriate analgesia. After a survival period of 3–4 days, 
the mice were reanaesthetised with pentobarbitone (30 mg, 
intraperitoneally) and perfused through the heart with a fixa-
tive that contained 4% freshly depolymerised formaldehyde 
in phosphate buffer. A relatively short survival time was 
used in these experiments because of the possibility that 
levels of CTb in retrogradely labelled neurons could decline 
at longer post-operative times. The spinal cord segments 
from T12–L6 were removed and post-fixed for 2 h in the 
same fixative.
To investigate the axonal projections of substance 
P-expressing neurons, we made a single injection of AAV.
flex.eGFP (8.6 or 4.3 × 108 gene copies in 300 nl) into the L5 
spinal cord segments of four additional male  Tac1Cre mice 
aged 6–8 weeks (23–28 g). The procedure was the same 
as that described above, except that these animals did not 
receive an injection of CTb. Following a survival time of 
7 days (n = 2) or 29 days (n = 2), the mice were reanaesthe-
tised and fixed by perfusion as described above. In these 
cases, the entire spinal cord and brain were removed and 
post-fixed in the same way. In addition, the L4 and L5 dorsal 
root ganglia on the right (ipsilateral) side were removed from 
the two mice that survived 29 days.
Immunocytochemical processing and confocal 
microscopy
In the mice that received injections of both CTb and AAV.
flex.eGFP, a block of tissue corresponding to the T13–L1 
segments was cut into 60 µm-thick transverse sections with 
a vibrating blade microtome (Leica VT 1200). The sections 
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were cut sequentially into 4 bottles, and the sections from 
one bottle from each mouse were incubated in anti-CTb at 
1:200,000 and processed with an immunoperoxidase method 
to reveal the CTb injection site, as described previously 
(Cameron et al. 2015).
Another block of tissue corresponding to the L4–5 seg-
ments from each of these mice was cut transversely into four 
series of 60 µm-thick transverse sections, three of which 
were used in the present study. The sections were reacted 
for immunofluorescence staining as described previously 
(Gutierrez-Mecinas et al. 2017). Briefly, they were incu-
bated for 3 days at 4 °C in mixtures of primary antibodies 
and then overnight in mixtures of species-specific second-
ary antibodies that were raised in donkey. The secondary 
antibodies were conjugated to Alexa 647, Rhodamine Red 
or Pacific Blue (Jackson ImmunoResearch, West Grove, PA) 
and were used at 1:500 (Alexa 647), 1:100 (Rhodamine Red) 
or 1:200 (Pacific Blue). After immunoreaction, the sections 
were mounted in antifade medium and stored at − 20 °C. 
All antibodies were diluted in phosphate-buffered saline 
that contained 0.3% Triton X-100 and 5% normal donkey 
serum. The sources and dilutions of the primary antibodies 
are shown in Table 1. The combinations of primary anti-
bodies used in this part of the study were as follows: (1) 
CTb and NeuN (chicken antibody); (2) CTb, NeuN (guinea-
pig antibody), and Pax2; and (3) CTb, NeuN (guinea-pig 
antibody), and PKCγ. The sections from the first reaction 
were subsequently counterstained with the nuclear stain 
4′,6-diamidino-2-phenylindole (DAPI).
From the animals that received only injections of AAV.
flex.eGFP, transverse sections were cut from each spinal 
segment from T13 to S2, as well as from some of the more 
rostral spinal segments. In addition, coronal sections of brain 
that included the medulla, lateral parabrachial area (LPb) 
and periaqueductal grey matter (PAG) were also obtained 
from these mice. Sections were reacted for immunofluores-
cence as described above. They were incubated in antibodies 
against eGFP and VGLUT2, which were used to confirm the 
presence of axonal boutons originating from  eGFP+ neu-
rons, most of which are excitatory (Gutierrez-Mecinas et al. 
2017), and also to define the location of the LSN, which con-
tains a high density of VGLUT2-immunoreactive terminals 
(Olave and Maxwell 2004; Todd et al. 2003). Immunostain-
ing with the eGFP antibody was used to amplify the fluo-
rescence of eGFP, to make axonal staining more clearly vis-
ible, and the eGFP antibody was detected with a secondary 
antibody conjugated to Alexa 488 (1:500). In some cases, 
antibodies against substance P and somatostatin were also 
used to identify axons that were likely to have originated 
from neurons in laminae I–II that express both these neu-
ropeptides (Gutierrez-Mecinas et al. 2017). Some sections 
from the L4-5 segments were reacted with antibodies against 
calcitonin gene-related peptide (CGRP), to test whether 
eGFP-labelled axons included substance P-expressing pri-
mary afferents, which co-express CGRP (Ju et al. 1987). The 
ipsilateral L4 and L5 dorsal root ganglia from the mice that 
survived 29 days after AAV.flex.eGFP were mounted intact 
in antifade medium.
Tissue with fluorescent labelling was scanned with a 
Zeiss LSM710 confocal microscope equipped with Argon 
multi-line, 405 nm diode, 561 nm solid state, and 633 nm 
HeNe lasers.
Neurochemical characterisation of neurons in L5 
that were retrogradely labelled from T13/L1 
segments
From the mice that received both CTb and AAV.flex.
eGFP injections, two L4–5 sections from each animal 
that had been reacted with each antibody combination 
were selected for scanning and analysis, and this selec-
tion was made before CTb immunostaining was viewed. 
For the quantitative analysis of eGFP-expressing cells, we 
chose two sections that contained high numbers of  eGFP+ 
Table 1  Antibodies used in this 
study
a For immunoperoxidase reaction
Antibody Species Catalogue no Dilution Source
CTb Goat 703 1:5000
1:200,000a
List biological
NeuN Chicken 266 006 1:1000 Synaptic systems
NeuN Guinea pig 266 004 1:500 Synaptic systems
Pax2 Rabbit 716 000 1:1000 Life technologies
PKCγ Rabbit sc211 1:1000 Santa cruz biotechnology
GFP Chicken Abcam 1:1000 ab13970
Substance P Rat OBT06435 1:200 Oxford biotech
Somatostatin Rabbit T-4103 1:1000 Peninsula
VGLUT2 Guinea pig ab2251 1: 5000 Millipore
CGRP Guinea pig Bachem 1:10,000 T-5027
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cells, because some of the sections from the L4-5 block 
did not include the AAV.flex.eGFP injection site. Scans 
were obtained through a 40× oil-immersion lens (numeri-
cal aperture 1.3) to generate z series (1 µm z separation), 
such that the entire cross-sectional area of the ipsilateral 
dorsal horn through the full thickness of the section was 
included. The confocal scans were analysed with Neurolu-
cida for Confocal (MBF Bioscience, Williston, VT, USA) 
using a modification (Gutierrez-Mecinas et al. 2017) of the 
disector method (Sterio 1984). The reference and look-up 
sections were set between 10 and 15 µm apart. Because all 
quantitative analyses were performed on laminae I–II, we 
initially plotted the outline of the dorsal horn grey mat-
ter, and then located the lamina II–III border, either by 
the relatively low density of neurons in the inner half of 
lamina II (IIi), or by the presence of a plexus of PKCγ-
immunoreactive dendrites that occupy lamina IIi (Gutier-
rez-Mecinas et al. 2014).
For the analysis of eGFP expression among retrogradely 
labelled neurons, we used sections that had been reacted 
with NeuN and CTb antibodies, and counterstained with 
DAPI. Because the AAV.flex.eGFP injection did not always 
occupy the entire mediolateral width of the dorsal horn, we 
restricted the analysis to the region that contained a high 
density of  eGFP+ cells (Gutierrez-Mecinas et al. 2017), and 
this was initially plotted onto an outline of the superficial 
dorsal horn. Then, the channels corresponding to NeuN 
and DAPI were viewed, and all neurons for which the bot-
tom surface of the nucleus lay between the reference and 
look-up sections were marked on the drawing. The eGFP 
and CTb channels were then examined, and for each of the 
selected neurons, the presence or the absence of both eGFP 
and CTb was determined. A similar analysis was carried out 
for Pax2 and PKCγ on sections that had been reacted with 
the other two antibody combinations (NeuN, CTb, Pax2; 
NeuN, CTb, and PKCγ), except that in this case the disector 
sample selection involved identifying the bottom surface of 
the neuronal cell body (immunostained with NeuN), since 
these sections were not counterstained with DAPI. In addi-
tion, the entire mediolateral extent of laminae I–II of the 
dorsal horn was included in the analysis.
Because we have found that some substance P-expressing 
neurons in lamina I–II are inhibitory (Gutierrez-Mecinas 
et al. 2017), we also searched for Pax2 in the nuclei of ret-
rogradely labelled  eGFP+ cells in scans from the sections 
that had been reacted for CTb, NeuN, and Pax2. The CTb 
and eGFP channels were initially viewed with Neurolucida, 
and 415 lamina I–II  CTb+/eGFP+ cells were identified in the 
four mice (84–121 cells per mouse). The Pax2 channel was 
then switched on, and the presence or absence of Pax2 in the 
nucleus was recorded for each  CTb+/eGFP+ cell.
Identification of axons belonging to substance 
P‑expressing cells
We found that although intraspinal injection of AAV.flex.
eGFP in the  Tac1Cre mouse labelled cell bodies that were 
largely restricted to the injection site (Gutierrez-Meci-
nas et al. 2017), it also resulted in axonal labelling that 
extended several segments away from the injection. This 
presumably results from anterograde transport of the pro-
tein within the axons of substance P-expressing neurons. 
We, therefore, used tissue from the four mice that had only 
received this type of injection to examine the axonal pro-
jections of the eGFP-labelled cells. Since the retrogradely 
labelled  eGFP+ cells that were seen in L5 in the first part 
of the study must have had axons that travelled at least as 
far as the T13/L1 spinal level, our aim here was to identify 
axons of eGFP-labelled cells that could have accounted for 
the uptake and transport of CTb, i.e., those that reached 
the L1 segment.
For the four mice injected only with AAV.flex.eGFP, 
we initially determined the extent of the injection site by 
inspecting non-immunostained sections cut through the L4-5 
block and looking for  eGFP+ cell bodies. We then examined 
sections that had been reacted with antibodies against eGFP 
and VGLUT2 from several segments of spinal cord and from 
the brain, to investigate the distribution of eGFP-labelled 
axons at different segmental levels rostral and caudal to the 
injection site. Because  eGFP+ axons were sparsely distrib-
uted in laminae I and II in segments beyond the injection 
site (see Results), but extended rostrally for several segments 
in the LSN, we analysed the expression of VGLUT2, sub-
stance P and somatostatin in  eGFP+ axons within the LSN 
in the L1 segment. This antibody combination was used, 
because many of the substance P-expressing neurons in the 
superficial dorsal horn also contain somatostatin (Gutierrez-
Mecinas et al. 2017). Co-expression of the peptides in bou-
tons can, therefore, be used to identify axons that are likely 
to originate from these cells. A single section from the L1 
segment of each animal was scanned through a 63× oil-
immersion lens (numerical aperture 1.4) to give a z series 
of 45–55 optical sections at 0.3 µm z spacing. The eGFP and 
VGLUT2 channels were initially viewed, and the region cor-
responding to the LSN was identified based on the distribu-
tion of VGLUT2 immunostaining in axon terminals within 
the nucleus. Approximately 100  eGFP+/VGLUT2+ boutons 
were selected throughout the depth of the z series. The sub-
stance P and somatostatin channels were then viewed, and 
the presence or absence of each neuropeptide was assessed 
in all of the selected boutons. Five boutons of each neuro-
chemical type (with or without substance P or somatosta-
tin) from each animal were selected and their z depth was 
determined based on the number of optical sections (0.3 µm 
separation) in which they appeared. This was carried out to 
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test whether variation in size of the different types of bouton 
could have resulted in a sampling bias.
Characterisation of antibodies
The specificity of the CTb antibody is demonstrated by the 
lack of staining in regions that did not contain injected or 
transported tracer. The two NeuN antibodies were raised 
against a recombinant protein consisting of amino acids 
1–97 of mouse NeuN protein. When sections are double-
stained with either of these antibodies and a well-charac-
terised mouse antibody, each gives a staining pattern that 
is identical to that seen with the mouse antibody (E Polgár, 
unpublished observations). The Pax2 antibody is directed 
against amino acids 188–385 of the mouse protein, and rec-
ognizes bands of the appropriate size on Western blots of 
mouse embryonic kidney (Dressler and Douglass 1992). A 
Pax2 antibody has recently been shown to label all inhibi-
tory interneurons in the dorsal horn of adult rats (Larsson 
2017), and the staining pattern that we saw closely matched 
that reported by Larsson. The PKCγ antibody was raised 
against a peptide corresponding to the C terminus of mouse 
PKCγ, and we have shown that it stains identical structures 
to those that are labelled with a well-characterised guinea-
pig antibody against PKCγ (Sardella et al. 2011). The eGFP 
antibody was raised against recombinant full-length eGFP 
and the staining matches that of native eGFP fluorescence. 
The monoclonal substance P antibody detects the C-termi-
nal 5–8 amino acids of substance P, and does not appear 
to recognize neurokinin B in tissue sections (McLeod et al. 
2000). The somatostatin antibody is reported to show 100% 
cross-reactivity with somatostatin-28 and somatostatin-25, 
but none with substance P, and staining is blocked by pre-
incubation with somatostatin (Proudlock et al. 1993). The 
VGLUT2 antibody was raised against a synthetic peptide 
from rat VGLUT2, and we have shown that it stains identi-
cal structures to a well-characterised rabbit anti-VGLUT2 
(Todd et al. 2003). The CGRP antibody is raised against the 
full-length human α-CGRP and shows 100% cross reactivity 
with human and rat α-CGRP, human CGRP(8–37), chicken 
CGRP, and human β-CGRP (manufacturer’s specification). 
Staining with this antibody closely resembled that seen with 
a goat anti-CGRP in our previous study (Gutierrez-Mecinas 
et al. 2014).
Statistical analysis
Data from the analysis of retrogradely labelled cells were 
formatted into 2 × 2 contingency tables for each animal, with 
rows corresponding to the presence or absence of neuronal 
markers (eGFP, Pax2, and PKCγ) and columns to the pres-
ence or absence of CTb immunoreactivity. To determine 
whether there was a consistent difference in the proportions 
across the tables for the different cell types, we used the 
Mantel–Haenszel analysis (McDonald 2014). Breslow–Day 
testing for homogeneity of the odds ratio was conducted 
prior to computation of the Mantel–Haenszel odds ratio and 
95% confidence intervals.
Results
CTb injection sites
The CTb injection sites were found to be located at the 
T13–L1 segmental levels, based on post mortem identifi-
cation of the segments defined by dorsal root entry zones, 
and the characteristic shape of the grey matter in this region 
(Fig. 1). Although there was some variability in the size of 
injection sites, as judged from the immunoperoxidase reac-
tions, in all cases, they included the whole of laminae I–V 
of the right dorsal horn as well as the LSN. In each case, 
they were restricted to the right side of the spinal cord. We 
found that the injection site was present on between 4 and 7 
of the 60 µm-thick transverse sections obtained from a one in 
four series, and we, therefore, estimate that the rostrocaudal 
length of the injection site was between 1000 and 1700 µm.
Characterisation of retrogradely labelled neurons 
in the L5 segment
In sections from L5 that had been reacted with each of the 
antibody combinations, numerous CTb-labelled cells were 
observed throughout the mediolateral and dorsoventral 
extent of the superficial dorsal horn, as well as being present 
in deeper laminae (Fig. 2). Although retrogradely labelled 
cells were also present on the contralateral side, these were 
far less numerous, and were largely restricted to the deep 
dorsal horn and the medial part of the ventral horn. The 
eGFP injection sites were found to be located within L5, 
and the distribution of eGFP labelling was very similar to 
that reported in our previous study (Gutierrez-Mecinas et al. 
2017). There was a high density of  eGFP+ cells in lamina 
I and the outer half of lamina II (lamina IIo), and scattered 
cells were present in deeper laminae (Fig. 2). In all cases, 
these injection sites occupied at least two-thirds of the medi-
olateral extent of the superficial dorsal horn. The rostrocau-
dal extent of the  eGFP+ cells can be estimated, based on the 
finding that typically, between three and six sections from a 
one in four series of 60 µm sections contained eGFP-labelled 
cell bodies in the superficial dorsal horn. This suggests that 
cells were distributed along a rostrocaudal length of between 
~ 700–1400 µm. Since we find that the mean length of the 
L5 segment is 1.2 mm (EP, unpublished observations), it is 
likely that the injection site occupies on average approxi-
mately one segment in rostrocaudal length.
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Quantitative data obtained from the analyses of eGFP, 
Pax2, and PKCγ populations are shown in Tables 2, 3 and 
4, and examples of each type of immunostaining are illus-
trated in Figs. 3, 4, 5. To determine the proportion of all 
neurons in laminae I–II that were retrogradely labelled with 
CTb in the four mice, we pooled data from these analyses 
for each mouse. The mean number of lamina I–II neurons 
identified in the four mice was 875.8 (range 742–1094), 
and the proportion of these cells that were CTb immuno-
reactive was 33.7% (range 30–35.9%). This indicates that 
around one-third of the neurons in laminae I–II of the L5 
segment were retrogradely labelled from an injection into 
the T13–L1 region, and that despite differences in the extent 
of the CTb injection between the mice, the percentages of 
retrogradely labelled neurons were fairly similar. To com-
pare the frequency of retrograde labelling in laminae I and 
II, we drew the approximate position of the lamina I–II bor-
der, which was placed 20 µm below the dorsal surface of the 
grey matter (Ganley et al. 2015) and analysed cells in these 
two laminae separately. In lamina I, 44.1% (37.7–48.7%) 
of neurons were  CTb+, while for lamina II, the proportion 
was 29.4% (26.4–31.4%). We also tested whether there was 
a difference in the proportion of neurons in the medial and 
lateral halves of the superficial dorsal horn that were  CTb+ 
(Petko and Antal 2000), by drawing a line through the mid-
dle of the dorsal horn in the dorsoventral axis. The propor-
tions of laminae I–II neurons that were retrogradely labelled 
were very similar: 36% (31.1–41.5%) for the lateral part and 
33.3% (28.6–39.2%) for the medial part.
Within the three neuronal populations that we examined, 
we found substantial differences in the proportions of cells 
that were retrogradely labelled with CTb. The results for 
 eGFP+ cells are shown in Table 2. In the sections used to 
analyse these cells, 32.2% of all neurons (range 23.7–36.5%) 
were CTb immunoreactive and 20.3% (18.2–21.7%) were 
 eGFP+. The proportion of lamina I–II neurons that were 
 eGFP+ is very similar to the value that we previously 
reported (19.6%) following injection of AAV.flex.eGFP 
Fig. 1  CTb injection sites in the four mice that received injections of 
CTb and AAV.flex.eGFP. Sections through the T13–L1 block have 
been reacted by an immunoperoxidase method to reveal CTb. Note 
that although the extent of the injection site varied between the four 
mice, it consistently filled the upper part of the dorsal horn (lami-
nae I–IV) and the lateral spinal nucleus on the right side, but did not 
extend significantly across the midline. Scale bar = 500 µm
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into the  Tac1Cre mouse (Gutierrez-Mecinas et al. 2017). 
However, there was a clear difference in terms of retrograde 
labelling between those cells with eGFP and those without. 
Among  eGFP+ cells, 51.3% (36.8–59.5%) were CTb immu-
noreactive, while for eGFP-negative cells, the correspond-
ing proportion was 27.5% (24.1–32.8%). These proportions 
were significantly different (p < 0.001; Table 5), showing 
that  eGFP+ cells were more likely to be retrogradely labelled 
when compared to other neurons in laminae I–II (Fig. 3). 
Cells that were  eGFP+ accounted for 32.2% (23.7–36.5%) 
of the CTb-labelled lamina I–II neurons in these sections. 
None of the 415  CTb+/eGFP+ cells that were identified in 
the sections reacted for CTb, NeuN, and Pax2 were  Pax2+, 
indicating that all of the retrogradely labelled substance P 
cells were excitatory neurons.
In sections that were used to analyse Pax2, 36.3% 
(31.5–43.6%) of lamina I–II neurons were CTb-labelled 
(Table 3). We also found that 24.2% (21.6–27.3%) of all 
neurons were Pax2-immunoreactive, which is consistent 
with our previous estimate, based on immunostaining for 
GABA and glycine, that 26% of the neurons in laminae 
I–II are inhibitory (Polgár et al. 2013). Among  Pax2+ cells, 
13.3% (4.8–20.4%) were CTb immunoreactive, while the 
corresponding proportion for Pax2-negative cells was 43.5% 
(40.1–50%). These proportions were significantly different 
(p < 0.001; Table 5), showing that inhibitory neurons were 
significantly less likely to be retrogradely labelled when 
compared to excitatory neurons in laminae I–II (Fig. 4). 
Pax2-immunoreactive cells accounted for 8.7% (3.7–13.6%) 
of the CTb-labelled neurons in laminae I–II, indicating that 
Fig. 2  Retrograde labelling with CTb in the L5 segment of a  Tac1Cre 
mouse that had received injections of CTb into T13–L1 and AAV.
flex.eGFP into L5. The section has been scanned to reveal CTb (red), 
NeuN (blue), and eGFP (green). There are numerous CTb-labelled 
neurons, and the CTb staining appears in the perikaryal cytoplasm of 
these cells. They are particularly numerous in laminae I–II, occupy-
ing the full mediolateral extent of the dorsal horn, and are scattered 
throughout the deeper laminae. This section is close to the AAV.flex.
eGFP injection site, and there are many  eGFP+ cells, particularly in 
laminae I and IIo. Note that in this section, the  eGFP+ cells are not 
present in the extreme lateral part of the superficial dorsal horn, pre-
sumably resulting from lack of spread of the virus from the injection 
site. The dashed line represents the border between laminae II and III, 
and the box in the upper image shows the region illustrated in Fig. 3. 
The image is a projection of 11 optical sections at 1 µm z separation, 
with a pixel size of 0.297 µm. Scale bar = 100 µm
Table 2  CTb and eGFP in  Tac1Cre mice injected with CTb and AAV.
flex.eGFP
Contingency table showing the mean number of cells containing CTb 
and/or eGFP that were identified in laminae I–II in the stereological 
analysis of sections through the L5 segment. The ranges are indicated 
in brackets. Data were obtained from the four mice that were injected 
with CTb and AAV.flex.eGFP. Note that the analysis involved the 
region of the superficial dorsal horn (laminae I–II) that contained a 
high density of eGFP-labelled cells
CTb+ neurons CTb− neurons Total
eGFP+ neurons 26.8 (23–31) 27.5 (17–48) 54.3 (42–76)
eGFP− neurons 59.8 (40–90) 157.5 (120–251) 217.3 (164–341)
Total 86.5 (63–118) 185 (137–299) 271.5 (206–417)
Table 3  CTb and Pax2 in  Tac1Cre mice injected with CTb and AAV.
flex.eGFP
Contingency table showing the mean number of cells containing CTb 
and/or Pax2 that were identified in laminae I–II in the stereological 
analysis of sections through the L5 segment. The ranges are indicated 
in brackets. Data were obtained from the four mice that were injected 
with CTb and AAV.flex.eGFP
CTb+ neurons CTb− neurons Total
Pax2+ neurons 8.5 (3–12) 57.3 (39–71) 65.8 (49–80)
Pax2− neurons 89 (76–112) 116 (89–144) 205 (178–256)
Total 97.5 (82–121) 173.3 (128–215) 270.8 (227–336)
Table 4  CTb and PKCγ in  Tac1Cre mice injected with CTb and AAV.
flex.eGFP
Contingency table showing the mean number of cells with CTb and/
or PKCγ-immunoreactivity that were identified in laminae I–II in the 
stereological analysis of sections through the L5 segment. The ranges 
are indicated in brackets. Data were obtained from the four mice that 
were injected with CTb and AAV.flex.eGFP
CTb+ neurons CTb− neurons Total
PKCγ+ neurons 8 (6–12) 44.3 (33–58) 52.3 (45–65)
PKCγ− neurons 107 (82–142) 176.3 (154–199) 283.3 (260–310)
Total 115 (89–154) 220.5 (187–257) 335.5 (309–375)
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over 90% of the retrogradely labelled cells were excitatory 
neurons.
In the sections reacted to reveal PKCγ, 34.2% 
(28.8–45.2%) of lamina I–II neurons were CTb-labelled 
and 15.5% (13.2–17.3%) were PKCγ-immunoreactive 
(Table 3). Among the PKCγ cells, 15.9% (10.8–26.7%) were 
CTb-labelled, and these cells generally showed weak PKCγ-
immunoreactivity. For PKCγ-negative cells, the proportion 
that were CTb-labelled was 37.5% (31.5–48%). Again, these 
proportions were significantly different (p < 0.001; Table 5), 
showing that PKCγ-expressing neurons were significantly 
under-represented among those that were retrogradely 
labelled (Fig. 5). PKCγ cells accounted for 6.9% (5.9–7.9%) 
of the CTb-labelled neurons in laminae I–II.
Fig. 3  Retrograde labelling of eGFP-expressing cells in a  Tac1Cre 
mouse that had received injections of CTb at T13–L1 and AAV.flex.
eGFP at L5. This image shows part of laminae I–II from a single 
confocal optical section from L5 (pixel size 0.297 µm), and is from 
the field illustrated in Fig. 2. The section has been immunostained to 
reveal CTb (red) and NeuN (blue), while eGFP fluorescence appears 
green. Several CTb-labelled cells are present. Some of those that are 
also  eGFP+ are marked with arrows, while some  CTb+ cells that lack 
eGFP are marked with arrowheads. Scale bar = 20 µm
Fig. 4  Immunostaining for Pax2 in the L5 segment of a  Tac1Cre 
mouse that had received injections of CTb at T13–L1 and AAV.flex.
eGFP at L5. Part of laminae I–II is shown, containing several CTb-
labelled neurons. Most of these are Pax2-negative (four of which 
are indicated with arrowheads), and there are 2 Pax2+ CTb-labelled 
cells (arrows). The image is from a single optical section (pixel size 
0.297 µm). Scale bar = 20 µm
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eGFP‑labelled axons
In the four mice that only received injections of AAV.flex.
eGFP, injection sites were located in the L5 segment in each 
case, and were largely restricted to the right dorsal horn, 
although a few strongly labelled cells were present in the 
medial dorsal horn on the left side in two mice. In addition 
to brightly fluorescent cells within the injection site, some 
labelled cells were seen in the LSN and in the contralat-
eral dorsal horn, and these may have been labelled through 
retrograde transport from axons entering the injection site. 
However, eGFP-labelled cell bodies were not seen in any 
of the other segments examined. In all of the animals, there 
was extensive axonal staining that could be seen in segments 
both rostral and caudal to the injection site. The pattern of 
eGFP labelling in rostral segments in one of the 4-week sur-
vival mice is illustrated in Fig. 6. The distribution of  eGFP+ 
axons was generally similar between the four mice, but was 
considerably stronger and more extensive in the two animals 
that had survived 4 weeks after injection. There was consist-
ently very dense labelling in the ipsilateral LSN in lumbar 
segments, and labelled axons within the LSN extended at 
least as far as T13 in the two mice with 1-week survival, 
and as far as upper thoracic segments in the other two mice 
(see below). The eGFP labelling within the LSN included 
both varicosities and intervaricose axons. There were also 
numerous  eGFP+ axon branches that ramified in lamina I 
and these extended for at least three segments rostral to the 
injection site (i.e., into the L2 segment). Although we did 
not analyse these formally, we noted that the great majority 
of the boutons in lamina I were  VGLUT2+. In addition, there 
was a diffuse plexus of axons in deeper laminae (III–V) and 
scattered axons in the intermediate grey matter. However, 
few eGFP-labelled axons were visible in lamina II at dis-
tances more than one segment away from the injection site. 
In addition, in all animals, there was a distinct and relatively 
compact bundle of non-varicose axons in the dorsal part 
of the lateral funiculus on the contralateral (left) side that 
extended at least as far as T3 in the 1-week survival animals, 
and as far as C1 in the 4-week survival mice. The location 
of this bundle closely matches the distribution of antidromic 
activation sites for contralateral lamina I neurons that were 
found to project to the midbrain in the rat (McMahon and 
Wall 1983, 1985). Numerous eGFP-labelled axons were seen 
Fig. 5  Immunostaining for PKCγ in the L5 segment of a  Tac1Cre 
mouse that had received injections of CTb at T13–L1 and AAV.flex.
eGFP at L5. The field shows part of lamina II, and several PKCγ pos-
itive cells are visible in the lower half. Most of these are not labelled 
with CTb, but a single CTb-containing cell with weak PKCγ is pre-
sent (arrow). Several CTb-labelled cells that lack PKCγ are present, 
and some of these are marked with arrowheads. The image is from a 
single optical section (pixel size 0.346 µm). Scale bar = 20 µm
Table 5  Analysis of odds ratios 
for colocalisation of CTb and 
different neuronal markers
Neuronal marker Breslow–Day 
significance
Mantel–Haenszel test of condi-
tional independence
Estimate of com-
mon odds ratio
95% 
confidence 
interval
χ2MH df Significance
eGFP 0.159 36.1 1 < 0.001 2.55 1.88–3.46
Pax2 0.170 78.0 1 < 0.001 0.19 0.13–0.28
PKCγ 0.676 37.2 1 < 0.001 0.30 0.20–0.45
2386 Brain Structure and Function (2018) 223:2377–2392
1 3
2387Brain Structure and Function (2018) 223:2377–2392 
1 3
in the brains of the two mice that survived 4 weeks after 
intraspinal injection of AAV.flex.eGFP. Although we did 
not perform a detailed analysis, we observed many labelled 
axons with varicosities in regions that are known to receive 
input from projection neurons in laminae I and III–IV (Todd 
et al. 2000), including the medullary reticular formation, the 
LPb and the PAG (Fig. 7). This indicates that some of the 
eGFP-labelled cells were projection neurons belonging to 
the spinoparabrachial and spinomesencephalic tracts, and 
these are likely to have included the large lamina I neu-
rons, together with at least some of those in deeper laminae 
(III–V). The labelling of projection neurons in the  Tac1Cre 
mouse is consistent with the report that some spinopabra-
chial neurons express substance P (Blomqvist and Macker-
lova 1995; Cameron et al. 2015). No  eGFP+ axons were seen 
in the brains of the two mice that survived 1 week after the 
intraspinal injection, and this indicates that a longer time is 
required to reveal axons and terminal arborisations within 
the brain.
Many  eGFP+ axons were seen in the LSN ipsilateral 
to the injection site (Fig. 6). These were most numerous 
close to the injection site and gradually decreased in den-
sity in more rostral and caudal segments. In the caudal 
direction,  eGFP+ axons extended at least as far as the S2 
segment (data not shown). The eGFP labelling within the 
LSN consisted of both intervaricose segments and axonal 
boutons, and the latter could be identified based on the 
presence of VGLUT2 (Fig. 8). In three of the mice, we 
estimated the proportion of  eGFP+ varicosities that were 
VGLUT2-immunoreactive in the ipsilateral LSN of the L1 
segment. We counted between 91 and 115 varicosities per 
mouse (mean 102) and found that 91.4–95% (mean 93.3%) 
of these were  VGLUT2+. Between 86 and 107 (mean 97, 
n = 4 mice),  eGFP+/VGLUT2+ boutons in the ipsilateral 
LSN at L1 were analysed for neuropeptide expression. 
Within this population, 72% (69–84%) were substance P 
immunoreactive, and 75% (57–87%) of these were also 
somatostatin immunoreactive. Very few of the  eGFP+ bou-
tons (~ 5%) were somatostatin immunoreactive and sub-
stance P negative. The length of boutons along the z-axis 
varied little among the different neurochemical types. 
Mean values were 1.5 µm for substance  P+/somatostatin+, 
1.6 µm for substance  P+/somatostatin−, and 1.5 µm for 
substance  P−/somatostatin−. Differences in z-axis length 
of boutons is, therefore, unlikely to have resulted in a bias 
towards any of these populations.
We used two approaches to determine whether any of 
the eGFP-labelled axons were of primary afferent origin. 
First, we examined the ipsilateral L4 and L5 dorsal root gan-
glia from two of the injected mice. We did not detect any 
 GFP+ cell bodies in any of these ganglia (data not shown). 
In addition, we analysed sections from the injected spinal 
cord segments that had been reacted for CGRP, which is 
coexpressed with substance P in primary afferents (Ju et al. 
1987). Although numerous CGRP immunoreactive axons 
were seen in the superficial dorsal horn, none of these was 
 eGFP+ (Fig. 9). This suggests that there was little or no 
transfection in substance P-expressing primary afferents or 
their central terminals.
Discussion
The main findings of this study are: (1) that around 30% 
of neurons in laminae I–II of the L5 segment were retro-
gradely labelled following injection of CTb into the ipsi-
lateral side of the spinal cord at the T13–L1 level; (2) that 
among these neurons, substance P-expressing excitatory 
neurons were significantly over-represented, whereas inhibi-
tory interneurons and PKCγ-expressing excitatory interneu-
rons were under-represented; (3) that intraspinal injection 
of AAV.flex.eGFP into the L5 dorsal horn of  Tac1Cre mice 
resulted in sparse axonal labelling in lamina II more than a 
segment away from the injection site; and (4) that this injec-
tion labelled numerous axons in the ipsilateral LSN several 
segments rostrally, many of which were immunoreactive for 
both substance P and somatostatin, and, therefore, likely to 
have originated from substance P-expressing interneurons 
in the superficial dorsal horn.
Fig. 6  eGFP labelling in the spinal cord of a  Tac1Cre mouse that sur-
vived for 4  weeks after an intraspinal injection of AAV.flex.eGFP. 
The pattern of labelling is shown at several levels. For the injection 
site, which was in the caudal part of the L5 segment, the left panel 
shows native eGFP fluorescence (green) combined with a dark-field 
transmitted image (magenta), while the right panel shows eGFP. For 
all other segments, the left panel shows immunostaining for eGFP 
(green) and VGLUT2 (magenta), while the right panel shows eGFP 
immunoreactivity. Close to the injection site in L5, there are numer-
ous  eGFP+ cells on the ipsilateral (ipsi) side, which are concentrated 
in the superficial dorsal horn, but scattered in deeper laminae. Axonal 
eGFP labelling is seen at all of the other segmental levels illustrated. 
There is a cluster of axons in the dorsal part of the lateral funiculus 
on the contralateral (contra) side (arrows), which can be clearly seen 
from L2 to C5, and this presumably consists of ascending spinopa-
rabrachial fibres. There is a dense bundle of axons that ascends within 
the ipsilateral LSN (arrowhead), and although this progressively 
diminishes further away from the injection site, it is clearly visible 
at T13. Individual eGFP-labelled axons can be seen in the ipsilateral 
LSN in more rostral segments. Scattered axons are also present in the 
ipsilateral dorsal horn. These are most numerous in L4 and progres-
sively diminish up to T11. Although some of these are in the super-
ficial dorsal horn, these are virtually restricted to lamina I and do not 
extend beyond T13. There are few eGFP axons in lamina II in L2 and 
virtually none in this lamina in more rostral segments. Insets show 
higher magnification views of the axonal labelling in the ipsilateral 
LSN at the T13 level and in the superficial dorsal horn at L2. Pixel 
sizes were 0.83 µm (C5, T3, T13), 0.415 µm (T11) 0.208 µm (L2, 
L4), and 0.503 µm (L5). Scale bars = 500 µm for the main part of the 
figure and 50 µm for the insets
◂
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Propriospinal  Tac1+ neurons and the LSN
In the present study, we used injections of AAV.flex.eGFP 
into the  Tac1Cre mouse to identify the cell bodies of sub-
stance P-expressing neurons (Gutierrez-Mecinas et  al. 
2017). An additional advantage of this approach is that 
the anterograde transport of eGFP within transfected cells 
allowed us to follow the axons of substance P-expressing 
neurons with cell bodies that were located close to the injec-
tion site. As reported previously, we found that injection of 
the viral vector resulted in labelling not only of neurons in 
laminae I–II, but also of cells in deeper laminae. Although 
the labelled cells included projection neurons, the great 
majority of those in the superficial dorsal horn will have 
been substance P-expressing excitatory interneurons (Gut-
ierrez-Mecinas et al. 2017). Substance P-expressing primary 
afferents do not enter the LSN (Bresnahan et al. 1984; Cliffer 
et al. 1988; Giesler and Elde 1985; Sikandar et al. 2017), 
and we did not detect CGRP in any of the eGFP-labelled 
boutons, indicating that these did not originate from primary 
afferents. The eGFP-labelled axons within LSN must, there-
fore, have originated from spinal neurons. Some of these 
axons may have been collaterals of the spinoparabrachial 
neurons (Szucs et al. 2010), or have arisen from neurons 
in deeper laminae or from the LSN itself. However, it is 
likely that many were derived from interneurons in laminae 
I–II, since 75% of the substance P-immunoreactive axonal 
boutons that we identified also contained somatostatin. The 
rationale for using this approach is that somatostatin expres-
sion in the spinal cord is largely restricted to laminae I–II, 
where it can be detected in at least 70% of the excitatory 
substance P-containing neurons (Gutierrez-Mecinas et al. 
2017). Importantly, somatostatin does not co-localise with 
substance P in primary afferents (Li et al. 2016; Usoskin 
et al. 2015; Hokfelt et al. 1976; Nagy and Hunt 1982), and 
is thought not to be expressed in lamina I projection neurons 
(Duan et al. 2014) or LSN neurons (Allen Spinal Cord Atlas. 
http://mouse spina l.brain -map.org/). Although there are scat-
tered somatostatin cells in deeper dorsal horn laminae, most 
of these are inhibitory (Duan et al. 2014; Proudlock et al. 
1993). While we cannot rule out a contribution from cells in 
deeper laminae, it is most likely that boutons in the LSN that 
contained VGLUT2 together with both these neuropeptides 
originated from substance P-expressing excitatory interneu-
rons in laminae I–II. Although it might be expected that 
all axonal boutons belonging to  Tac1+ cells would contain 
substance P, we have found that the level of immunoreactiv-
ity for the peptide is generally much lower in axons belong-
ing to substance P-expressing interneurons than in primary 
afferents (MGM and AJT, unpublished observations), and 
it was presumably below the detection threshold for immu-
nocytochemistry in some boutons belonging to these cells.
Szucs et al. (2010) have reported that axon collaterals of 
some lamina I projection neurons arborise within the dorsal 
horn, and it is likely that both these and substance P-express-
ing interneurons contributed to the axonal staining seen in 
this region close to the injection site. However, we observed 
relatively few eGFP-labelled axons within the superficial 
dorsal horn in rostral lumbar segments, and these were 
largely restricted to lamina I. Taken together with our finding 
Fig. 7  eGFP-labelled axons in the brain of a  Tac1Cre mouse that had 
received an intraspinal injection of AAV.flex.eGFP with a 4-week 
survival. a Dark-field image through the region surrounding the supe-
rior cerebellar peduncle (scp) includes the lateral parabrachial area 
(LPb), the caudal part of the periaqueductal grey matter (PAG) and 
part of the aqueduct (Aq). b, c eGFP labelling (green) is shown in a 
single confocal optical section (pixel size 2.372 µm) with and without 
the dark-field image (magenta). A dense plexus of labelled axons can 
be seen in the LPb, and this extends into the PAG (both marked with 
arrows). These images are taken from the same animal as that illus-
trated in Fig. 6, which had survived for 29 days after the intraspinal 
injection. Scale bar = 500 µm
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of extensive axonal labelling in the LSN, this strongly sug-
gests that the LSN represents a major route through which 
substance P-expressing cells in laminae I–II of the L5 seg-
ment were retrogradely labelled following injection of CTb 
into the T13/L1 region and that this nucleus is an important 
target for propriospinal substance P-expressing excitatory 
interneurons.
The discrepancy between the results reported by Bice and 
Beal (1997b) and those of Petko and Antal (2000, 2012) are 
likely to be explained by our finding that at least some of 
the propriospinal neurons (those that express substance P) 
give rise to axons that arborise within the LSN, but do not 
re-enter the superficial dorsal horn in significant numbers. 
Although substance P-expressing cells only accounted for 
around one-third of the propriospinal neurons in laminae 
I–II, if the remaining propriospinal neurons have interseg-
mental projections that are restricted to the LSN, this would 
explain the lack of retrogradely labelled cells more than a 
segment away from tracer injections that are limited to the 
dorsal horn (Petko and Antal 2000, 2012).
We found that around 34% of neurons in laminae I–II of 
the mouse L5 segment project at least 5 segments rostrally, 
and this is considerably higher than the proportion (~ 12%) 
of superficial dorsal horn neurons in the L1 segment that 
were labelled from T5 in the rat, a distance of nine segments 
(Bice and Beal 1997b). Although there could be differences 
related to the species and the segment into which the injec-
tion was made, the most likely explanation for the higher 
proportion that we see is that there is a gradual reduction 
in the number of cells projecting to more distant segments. 
This would be consistent with our finding that eGFP label-
ling in the LSN progressively decreases with increasing dis-
tance from the injection site.
Role of the LSN
The LSN, which was originally identified by Gwyn and 
Waldron (1968), has been the subject of several anatomical 
and functional studies. It is present throughout the rostro-
caudal length of the spinal cord in rodents, but is displaced 
Fig. 8  Neuropeptides in eGFP-labelled axons in the LSN. a, b Confo-
cal image showing the lateral part of the dorsal horn and lateral spinal 
nucleus (LSN, indicated by the dashed line in b) in a section from 
the L1 segment of a  Tac1Cre mouse that had received an intraspinal 
injection of AAV.flex.eGFP. Immunostaining for substance P (SP, 
magenta) and eGFP (green) is shown. Note the intense labelling for 
substance P in profiles in the superficial dorsal horn, and the much 
weaker staining in the LSN. The box indicates the region of LSN 
that is shown at higher magnification in c–g. c–g These images show 
immunostaining for eGFP (green), substance P (red), somatostatin 
(SST, blue), and VGLUT2 (grey). Four eGFP-labelled boutons, all 
of which are VGLUT2-positive, are indicated. Three of these (shown 
with arrows) are immunoreactive for both substance P and somato-
statin, while one (arrowhead) is only immunoreactive for substance 
P. All images are from a single confocal optical section (pixel size 
0.082 µm). Scale bars a, b = 50 µm; c–g = 5 µm
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by the lateral cervical nucleus in the upper cervical cord 
(Giesler and Elde 1985). Anatomical studies have shown that 
it receives very little direct primary afferent input (Bresna-
han et al. 1984; Sikandar et al. 2017; Cliffer et al. 1988), 
with the exception of a few visceral afferents (Neuhuber 
1982; Sugiura et al. 1989). However, it has a rich network of 
neuropeptide-expressing axons that are thought to originate 
from local dorsal horn neurons (Cliffer et al. 1988; Giesler 
and Elde 1985; Olave and Maxwell 2004). Many LSN neu-
rons project supraspinally to the brainstem and diencephalon 
(Burstein et al. 1990; Menetrey et al. 1980, 1982; Olave and 
Maxwell 2004). Interestingly, many of these cells (including 
the projection neurons) are immunoreactive for the neuro-
kinin 1 receptor (Littlewood et al. 1995; Olave and Max-
well 2004; Ding et al. 1995), and application of substance 
P depolarises cells in this nucleus (Jiang et al. 1999). Since 
substance P-expressing primary afferents do not enter the 
LSN, the main source of substance P to activate the receptor 
is presumably spinal interneurons, including those with long 
propriospinal axons.
There have been relatively few in vivo electrophysiologi-
cal studies of LSN neurons. Menetrey et al. (1980) recorded 
from 15 spinoreticular neurons in the midlumbar part of the 
rat LSN and found that only 2 of these had clear receptive 
fields, which covered the whole ipsilateral hindlimb. The 
remaining units had poorly defined fields on the proximal 
part of the limb that could extend onto the scrotum or base 
of the tail. These responded variably to stimuli applied to the 
skin and deep tissues, including extreme joint movement. 
Sikandar et al. (2017) recently reported that LSN neurons in 
the rat were activated mainly by noxious stimulation of deep 
tissues. However, they could be sensitised by intramuscu-
lar hypertonic saline, following which they developed large 
cutaneous receptive fields, and responded to brushing of the 
skin, as well as showing heightened responses to noxious 
stimuli.
Our results suggest that many substance P-expressing 
cells send ascending and descending axons into the LSN and 
that these give rise to boutons (and presumably synapses) 
over a considerable rostrocaudal extent of the nucleus. As 
discussed above, a similar arrangement may also apply to 
other propriospinal neurons in laminae I–II. The proprio-
spinal input to LSN is likely to be predominantly excitatory, 
since excitatory neurons outnumbered inhibitory neurons 
among those with long propriospinal connections. However, 
our finding that 13% of inhibitory neurons have long pro-
priospinal projections suggests that these may give rise to 
large inhibitory receptive fields for LSN cells. Until now, 
it has been assumed that the input to LSN from superficial 
dorsal horn neurons was exclusively from cells in the same 
or nearby segments, because Cliffer et al. (1988) saw no 
reduction in neuropeptide content in the LSN at L4 follow-
ing spinal lesions (including complete transection) at low 
thoracic or upper lumbar levels. Our findings show that 
there are significant propriospinal inputs from substance 
P-expressing neurons that can extend for at least five seg-
ments. However, these are presumably greatly outnumbered 
by inputs arising from the same or adjacent segments, and 
this would explain the lack of neuropeptide depletion seen 
by Cliffer et al. Since substance P-expressing interneurons 
in laminae I–II can respond to a variety of noxious stimuli 
delivered to the skin (Gutierrez-Mecinas et al. 2017), these 
long propriospinal connections are likely to contribute to 
the extensive (whole limb) receptive fields seen for some 
LSN cells by Menetrey et al. (1980) and the development of 
Fig. 9  Lack of eGFP labelling in CGRP-containing primary affer-
ents. Confocal images showing immunoreactivity for eGFP (green) 
and CGRP (magenta) in the superficial dorsal horn from a  Tac1Cre 
mouse that had received an intraspinal injection of AAV.flex.eGFP. 
The section is taken from the L4-L5 junction, just rostral to the injec-
tion site. Note that although there are numerous eGFP- and CGRP-
immunoreactive axons, there is no colocalisation of the two markers. 
The images are projections of five optical sections at 1 µm z spacing 
(pixel size 0.16 µm). Scale bar = 50 µm
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large receptive fields following sensitisation by intramus-
cular hypertonic saline, reported by Sikandar et al. (2017). 
Although PKCγ-expressing neurons were under-represented 
among the cells with long propriospinal projections, ~ 15% 
of these cells were retrogradely labelled. PKCγ neurons 
are thought to be activated by innocuous tactile stimuli 
(Neumann et al. 2008), and if the propriospinal PKCγ cells 
innervate the LSN, they may give rise to the large brush-
sensitive receptive fields that are seen following sensitisation 
(Sikandar et al. 2017).
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